Success Metrics

Active Trials
4(80%)

Phase Distribution

Ph phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

5

all time

Status Distribution
Active(5)

Detailed Status

Recruiting4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
4
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

not_yet_recruiting120%
recruiting480%

Recent Activity

4 active trials
Showing 5 of 5
recruitingphase_1

GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study

NCT07457281
not_yet_recruitingphase_1

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

NCT07307053
recruitingphase_1

Study of GV20-0251 in Participants With Solid Tumor Malignancies

NCT07070518
recruitingphase_1

A Study of GV20-0251 in Advanced or Refractory Solid Tumors

NCT07106827
recruitingphase_1

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

NCT05669430

Clinical Trials (5)

Showing 5 of 5 trials
NCT07457281Phase 1

GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study

Recruiting
NCT07307053Phase 1

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Not Yet Recruiting
NCT07070518Phase 1

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Recruiting
NCT07106827Phase 1

A Study of GV20-0251 in Advanced or Refractory Solid Tumors

Recruiting
NCT05669430Phase 1

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5